Scientific Expertise

Check out this webinar where we discuss current approaches available for therapeutic and vaccine Bioanalytical assessments and regulatory requirements in clinical research.

It was October 2015 when the US immunotherapy market was celebrating its first-ever FDA-approved oncolytic virus therapy, talimogene laherparepve (T-VEC). Developed by Amgen, this new genre of immunotherapy demonstrated immense efficacy in treating advanced melanoma.

Check out the latest BioPharma Newsletter from the Eurofins Group to learn about new services and analytical techniques, research projects, major events and other related topics.

May 27, 2021

Ashley Brant, Senior Scientific Director at Eurofins Bioanalytical Services, discusses the importance of critical reagents in assay performance, the challenges of changing reagents, and how Eurofins manages expiry and re-test dates using a Test Method Summary Sheet. She also shares her views on the future evolution of critical reagent management.

Check out the latest Eurofins Viracor BioPharma Press Releases:

Check out the latest BioPharma Newsletter from the Eurofins Group to learn about new services and analytical techniques, research projects, major events and other related topics.

Dec 1-3

RT-qPCR and Sequencing Testing Supporting SARS-CoV-2 Vaccine Clinical Trials

Presented By Mark Wissel

This informative webinar; featuring Karina Eterovic, PhD, R&D Director of Oncology Diagnostics at Eurofins Viracor, entitled: Exploring the application of comprehensive genomic profiling in oncology therapy development.

Sept 28 - Oct 1

qPCR/sequencing assay development to support vaccine clinical studies and trials

Presented by Mark Wissel

Jul 29

This informative webinar, featuring our flow cytometry expert, Dr. Brian Maybruck, will focus on the use of Flow Cytometry for rare cell quantitation, and its application in drug development.